Seek Returns

A vs. AVTR: Agilent vs. Avantor Stock Comparison

How do Agilent (A) and Avantor (AVTR) stack up? This page sets them side by side across company profile, performance and risk, profitability, growth, financial strength, dividends, and valuation, with selected fundamentals also measured against each stock's industry-group peers.

Company Profile

Agilent (A) and Avantor (AVTR) are both classified in the Life Sciences Tools & Services sub-industry within the broader Life Sciences Tools & Services industry, placing them in the closest GICS peer bucket.

Company profile comparison for Agilent (A) and Avantor (AVTR)
Profile ItemAAVTR
NameAgileThought, Inc. Class A Common StockAvantor, Inc.
Country/RegionUnited StatesUnited States
GICS SectorHealth CareHealth Care
GICS Industry GroupPharmaceuticals, Biotechnology & Life SciencesPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & ServicesLife Sciences Tools & Services
GICS Sub-IndustryLife Sciences Tools & ServicesLife Sciences Tools & Services
Market Capitalization49.28 billion USD10.48 billion USD
CurrencyUSDUSD
ExchangeNYSENYSE
Listing DateNovember 18, 1999May 17, 2019
Security TypeCommon StockCommon Stock

Price Performance

Cumulative Growth

A
AVTR
GSPC
Loading price history…
Agilent (A) vs. Avantor (AVTR), with S&P 500 (GSPC) for reference: Growth of a $10,000 investment over the past five years. Adjusted for dividends and splits.

Trailing Returns

Loading price history…
Trailing total returns for Agilent (A) and Avantor (AVTR). Returns over one year are annualized.

Calendar-Year Returns

Loading price history…
Calendar-year total returns for Agilent (A) and Avantor (AVTR). Each bar is that year's total return, measured year-end to year-end.

Performance Metrics

Price performance metrics for Agilent (A) and Avantor (AVTR)
MetricAAVTR
Total Return (1Y)22.92%36.41%
Total Return (3Y, Annualized)19.33%-5.02%
Total Return (5Y, Annualized)3.03%-16.62%

Risk Profile

Drawdown History

A
AVTR
GSPC
Loading price history…
Agilent (A) vs. Avantor (AVTR), with S&P 500 (GSPC) for reference: Drawdown from the running peak over the past five years. Each line shows the decline from its prior peak; 0% marks a new high.

Return Distribution

Loading price history…
Distribution of monthly total returns for Agilent (A) and Avantor (AVTR). Each bar is the share of months whose return fell in that 5% bucket.

Risk Metrics

Risk profile metrics for Agilent (A) and Avantor (AVTR)
MetricAAVTR
Volatility (1Y, Annualized)33.10%43.39%
Beta (5Y)1.220.94
Max Drawdown (5Y)-38.09%-82.42%
Avg. Volume (3M)2.25M8.56M

Risk-Adjusted Performance

Risk-Return Positioning

Loading chart…
A and AVTR are plotted by 1-year volatility (risk) and 1-year return. The dashed Capital Allocation Line runs from the risk-free rate through the shared industry median.

Risk-Adjusted Metrics

Risk-adjusted metrics for Agilent (A) and Avantor (AVTR)
MetricAAVTR
Sharpe Ratio (1Y)0.560.74
Sortino Ratio (1Y)0.961.17

Profitability

ROE (TTM)

Agilent (A) at 20.97% sits in the top ROE quartile, while Avantor (AVTR) at 5.91% is closer to the peer norm — stronger capital efficiency for A.

A

Pharmaceuticals, Biotechnology & Life Sciences industry group

20.97%

Max
109.18%
A
20.97%
Q3
6.23%
Median
-26.66%
Q1
-64.05%
Min
-167.77%

AVTR

Pharmaceuticals, Biotechnology & Life Sciences industry group

5.91%

Max
109.18%
Q3
6.23%
AVTR
5.91%
Median
-26.66%
Q1
-64.05%
Min
-167.77%
Loading chart…
Agilent (A) vs. Avantor (AVTR): A comparison of their ROE against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

Net Margin (TTM)

Agilent (A) at 19.53% keeps the most of each sales dollar — above its industry’s net margin range — and Avantor (AVTR) at 5.08% also retains a top-quartile share.

A

Pharmaceuticals, Biotechnology & Life Sciences industry group

19.53%

A
19.53%
Max
18.05%
Q3
4.78%
Median
0.00%
Q1
-4.14%
Min
-17.05%

AVTR

Pharmaceuticals, Biotechnology & Life Sciences industry group

5.08%

Max
18.05%
AVTR
5.08%
Q3
4.78%
Median
0.00%
Q1
-4.14%
Min
-17.05%
Loading chart…
Agilent (A) vs. Avantor (AVTR): A comparison of their net margin against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

Operating Margin (TTM)

Agilent (A) at 25.56% operates in the top operating margin quartile, ahead of Avantor (AVTR) at 8.19%, which runs around its industry’s norm.

A

Pharmaceuticals, Biotechnology & Life Sciences industry group

25.56%

Max
83.12%
A
25.56%
Q3
14.77%
Median
0.00%
Q1
-78.82%
Min
-207.40%

AVTR

Pharmaceuticals, Biotechnology & Life Sciences industry group

8.19%

Max
83.12%
Q3
14.77%
AVTR
8.19%
Median
0.00%
Q1
-78.82%
Min
-207.40%
Loading chart…
Agilent (A) vs. Avantor (AVTR): A comparison of their operating margin against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

Profitability Metrics

Profitability metrics for Agilent (A) and Avantor (AVTR)
MetricAAVTR
ROE (TTM)20.97%5.91%
ROA (TTM)8.63%2.83%
Net Margin (TTM)19.53%5.08%
Operating Margin (TTM)25.56%8.19%
Gross Margin (TTM)53.65%31.59%

Growth

Revenue Growth

Agilent (A) at 6.73% is around its peer norm for revenue growth, while Avantor (AVTR) at -3.41% drops into the bottom quartile, signaling weaker demand or pricing momentum.

Loading chart…
Agilent (A) vs. Avantor (AVTR): A comparison of their Revenue Growth across different time periods.

EPS Growth

Agilent (A) at 3.16% is around its peer norm for EPS growth, while Avantor (AVTR) at -175.00% drops into the bottom quartile, signaling weaker earnings momentum.

Loading chart…
Agilent (A) vs. Avantor (AVTR): A comparison of their EPS Growth across different time periods.

Growth Metrics

Growth metrics for Agilent (A) and Avantor (AVTR)
MetricAAVTR
Revenue Growth (YoY)6.73%-3.41%
Revenue Growth (3Y CAGR)0.48%-4.46%
EPS Growth (YoY)3.16%-175.00%
EPS Growth (3Y CAGR)3.02%--

Financial Strength

Current Ratio (MRQ)

Both Agilent (A) at 2.05 and Avantor (AVTR) at 1.89 run current ratio in the tighter-liquidity quartile of industry peers, leaving thinner cushions against current liabilities than typical competitors.

A

Pharmaceuticals, Biotechnology & Life Sciences industry group

2.05

Max
25.13
Q3
12.13
Median
5.52
Q1
2.47
A
2.05
Min
0.10

AVTR

Pharmaceuticals, Biotechnology & Life Sciences industry group

1.89

Max
25.13
Q3
12.13
Median
5.52
Q1
2.47
AVTR
1.89
Min
0.10
Loading chart…
Agilent (A) vs. Avantor (AVTR): A comparison of their current ratio against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

Debt / Equity (MRQ)

Both Agilent (A) at 0.56 and Avantor (AVTR) at 0.63 fund their balance sheets with roughly industry-typical debt-to-equity mixes.

A

Pharmaceuticals, Biotechnology & Life Sciences industry group

0.56

Max
1.42
Q3
0.65
A
0.56
Median
0.15
Q1
0.02
Min
0.00

AVTR

Pharmaceuticals, Biotechnology & Life Sciences industry group

0.63

Max
1.42
Q3
0.65
AVTR
0.63
Median
0.15
Q1
0.02
Min
0.00
Loading chart…
Agilent (A) vs. Avantor (AVTR): A comparison of their debt-to-equity ratio against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

Financial Strength Metrics

Financial strength metrics for Agilent (A) and Avantor (AVTR)
MetricAAVTR
Current Ratio (MRQ)2.051.89
Debt / Equity (MRQ)0.560.63
Net Debt / EBITDA1.153.40

Dividends

Dividend Yield (TTM)

Avantor (AVTR) pays no dividend (yield 0.00%) — it may be reinvesting, using buybacks, or simply not returning cash through dividends. Meanwhile Agilent (A) reports a yield of 0.59%, ranking against industry peers normally.

A

Pharmaceuticals, Biotechnology & Life Sciences industry group

0.59%

A
0.59%
Max
0.00%
Q3
0.00%
Median
0.00%
Q1
0.00%
Min
0.00%

AVTR

Pharmaceuticals, Biotechnology & Life Sciences industry group

0.00%

AVTR
0.00%
Max
0.00%
Q3
0.00%
Median
0.00%
Q1
0.00%
Min
0.00%
Loading chart…
Agilent (A) vs. Avantor (AVTR): A comparison of their dividend yield against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

Dividend Payout Ratio (TTM)

Avantor (AVTR) pays no dividend (payout 0.00%) — it may be reinvesting, using buybacks, or simply not returning cash through dividends. Meanwhile Agilent (A) reports a payout of 19.98%, ranking against industry peers normally.

A

Pharmaceuticals, Biotechnology & Life Sciences industry group

19.98%

A
19.98%
Max
0.00%
Q3
0.00%
Median
0.00%
Q1
0.00%
Min
0.00%

AVTR

Pharmaceuticals, Biotechnology & Life Sciences industry group

0.00%

AVTR
0.00%
Max
0.00%
Q3
0.00%
Median
0.00%
Q1
0.00%
Min
0.00%
Loading chart…
Agilent (A) vs. Avantor (AVTR): A comparison of their payout ratio against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

Dividend Metrics

Dividend metrics for Agilent (A) and Avantor (AVTR)
MetricAAVTR
Dividend Yield (TTM)0.59%0.00%
Dividend Payout Ratio (TTM)19.98%0.00%

Valuation

P/E Ratio (TTM)

Both Agilent (A) at 34.47 and Avantor (AVTR) at 30.94 land around their industries’ usual P/E ratio levels — neither is getting a clear earnings-multiple discount or premium versus peers.

A

Pharmaceuticals, Biotechnology & Life Sciences industry group

34.47

Max
85.34
Q3
43.46
A
34.47
Median
26.69
Q1
13.30
Min
0.07

AVTR

Pharmaceuticals, Biotechnology & Life Sciences industry group

30.94

Max
85.34
Q3
43.46
AVTR
30.94
Median
26.69
Q1
13.30
Min
0.07
Loading chart…
Agilent (A) vs. Avantor (AVTR): A comparison of their P/E ratio against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

P/S Ratio (TTM)

Avantor (AVTR) at 1.58 sits in the cheaper P/S ratio quartile while Agilent (A) at 6.68 prices around its industry’s middle — AVTR costs less per dollar of sales, though read it alongside growth and margins.

A

Pharmaceuticals, Biotechnology & Life Sciences industry group

6.68

Max
58.18
Q3
25.77
Median
7.30
A
6.68
Q1
3.01
Min
0.01

AVTR

Pharmaceuticals, Biotechnology & Life Sciences industry group

1.58

Max
58.18
Q3
25.77
Median
7.30
Q1
3.01
AVTR
1.58
Min
0.01
Loading chart…
Agilent (A) vs. Avantor (AVTR): A comparison of their P/S ratio against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

P/B Ratio (MRQ)

Avantor (AVTR) at 1.80 is valued about in line with its industry on P/B ratio, while Agilent (A) at 6.69 carries an above-peer premium to book — A is pricier on assets.

A

Pharmaceuticals, Biotechnology & Life Sciences industry group

6.69

Max
13.53
A
6.69
Q3
6.54
Median
3.25
Q1
1.69
Min
-5.59

AVTR

Pharmaceuticals, Biotechnology & Life Sciences industry group

1.80

Max
13.53
Q3
6.54
Median
3.25
AVTR
1.80
Q1
1.69
Min
-5.59
Loading chart…
Agilent (A) vs. Avantor (AVTR): A comparison of their P/B ratio against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

Valuation Metrics

Valuation metrics for Agilent (A) and Avantor (AVTR)
MetricAAVTR
P/E Ratio (TTM)34.4730.94
P/S Ratio (TTM)6.681.58
P/B Ratio (MRQ)6.691.80
Free Cash Flow Yield (TTM)2.15%4.21%